The role of pre-treatment diffusion-weighted mri in predicting long-term outcome of colorectal liver metastasis

British Journal of Radiology

Volumn 86, Issue 1030, 2013, Pages

  Tam, H H ^a   Collins, D J ^b   Brown, G ^a   Chau, I ^a   Cunningham, D ^a   Leach, M O ^b   Koh, D M ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; APPARENT DIFFUSION COEFFICIENT; ARTICLE; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; COLORECTAL LIVER METASTASIS; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; FEMALE; HUMAN; LEUKOCYTE COUNT; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTIVE VALUE; PREMEDICATION; PROGRESSION FREE SURVIVAL; TREATMENT RESPONSE; COLORECTAL TUMOR; DISEASE FREE SURVIVAL; KAPLAN MEIER METHOD; LIVER TUMOR; METASTASIS; METHODOLOGY; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SURVIVAL; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; DIFFUSION MAGNETIC RESONANCE IMAGING; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; ROC CURVE; SURVIVAL ANALYSIS;

EID: 84884565275     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr.20130281     Document Type: Article

References (31)

1. Scheele J, Stangl R, Altendorf-Hofmann A. Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg 1990;77:1241-6.
2. Gillams AR, Lees WR. Five-year survival in 309 patients with colorectal liver metastases treated with radiofrequency ablation. Eur Radiol 2009; 19:1206-13. doi: 10.1007/s00330-008-1258-5
3. Adam R, Pascal G, Castaing D, Azoulay D, Delvart V, Paule B, et al. Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases? Ann Surg 2004;240:1052-61; discussion 61-4. doi: 10.1016/j. recot.2013.03.002
4. Kohne CH, Cunningham D, Di CF, Glimelius B, Blijham G, Aranda E, et al. Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patients. Ann Oncol 2002;13: 308-17.
5. Le Bihan D. Molecular diffusion nuclear magnetic resonance imaging. Magn Reson Q 1991;7:1-30.
6. Le Bihan D, Breton E, Lallemand D, Aubin ML, Vignaud J, Laval-Jeantet M. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 1988;168:497-505.
7. Stejskal EO, Tanner JE. Spin diffusion measurements: spin-echo in the presence of a time dependent field gradient. J Chem Phys 1965;42:288-92.
8. Gauvain KM, McKinstry RC, Mukherjee P, Perry A, Neil JJ, Kaufman BA, et al. Evaluating pediatric brain tumor cellularity with diffusion-tensor imaging. AJR Am J Roentgenol 2001;177:449-54. doi: 10.2214/ajr.177.2.1770449
9. Sugahara T, Korogi Y, Kochi M, Ikushima I, Shigematu Y, Hirai T, et al. Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas. J Magn Reson Imaging 1999;9: 53-60.
10. Moffat BA, Chenevert TL, Meyer CR, McKeever PE, Hall DE, Hoff BA, et al. The functional diffusion map: an imaging biomarker for the early prediction of cancer treatment outcome. Neoplasia 2006;8: 259-67. doi: 10.1593/neo.05844
11. Oh J, Henry RG, Pirzkall A, Lu Y, Li X, Catalaa I, et al. Survival analysis in patients with glioblastoma multiforme: predictive value of choline-to-N-acetylaspartate index, apparent diffusion coefficient, and relative cerebral blood volume. J Magn Reson Imaging 2004;19:546-54.
12. Koh DM, Scurr E, Collins D, Kanber B, Norman A, Leach MO, et al. Predicting response of colorectal hepatic metastasis: value of pretreatment apparent diffusion coefficients. AJR Am J Roentgenol 2007;188: 1001-8. doi: 10.2214/AJR.06.0601
13. Cui Y, Zhang XP, Sun YS, Tang L, Shen L. Apparent diffusion coefficient: potential imaging biomarker for prediction and early detection of response to chemotherapy in hepatic metastases. Radiology 2008; 248:894-900. doi: 10.1148/radiol.2483071407
14. Dzik-Jurasz A, Domenig C, George M, Wolber J, Padhani A, Brown G, et al. Diffusion MRI for prediction of response of rectal cancer to chemoradiation. Lancet 2002; 360:307-8. doi: 10.1016/S0140-6736(02) 09520-X
15. Leek RD, Landers RJ, Harris AL, Lewis CE. Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast. Br J Cancer 1999;79: 991-5. doi: 10.1038/sj.bjc.6690158
16. Tŕedan O, Galmarini CM, Patel K, Tannock IF. Drug resistance and the solid tumor microenvironment. J Natl Cancer Inst 2007; 99:1441-54. doi: 10.1093/jnci/djm135
17. Brown JM. The hypoxic cell: a target for selective cancer therapy -eighteenth Bruce F. Cain Memorial Award lecture. Cancer Res 1999;59:5863-70.
18. Uematsu T, Kasami M, Yuen S. Neoadjuvant chemotherapy for breast cancer: correlation between the baseline MR imaging findings and responses to therapy. Eur Radiol 2010;20: 2315-22. doi: 10.1007/s00330-010-1813-8
19. Outwater E, Tomaszewski JE, Daly JM, Kressel HY. Hepatic colorectal metastases: correlation of MR imaging and pathologic appearance. Radiology 1991;180:327-32.
20. Oto A, Zhu F, Kulkarni K, Karczmar GS, Turner JR, Rubin D. Evaluation of diffusionweighted MR imaging for detection of bowel inflammation in patients with Crohn's disease. Acad Radiol 2009;16:597-603. doi: 10.1016/j.acra.2008.11. 009
21. Denkert C, Loibl S, Noske A, Roller M, Muller BM, Komor M, et al. Tumorassociated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer. J Clin Oncol 2010;28:105-13. doi: 10.1200/JCO.2009.23.7370
22. Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Paǵes C, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006;313:1960-4. doi: 10.1126/science.1129139
23. Klintrup K, Makinen JM, Kauppila S, Vare PO, Melkko J, Tuominen H, et al. Inflammation and prognosis in colorectal cancer. Eur J Cancer 2005;41:2645-54. doi: 10.1016/j.ejca.2005.07.017
24. Nagtegaal ID, Marijnen CA, Kranenbarg EK, Mulder-Stapel A, Hermans J, van de Velde CJ, et al. Local and distant recurrences in rectal cancer patients are predicted by the nonspecific immune response; specific immune response has only a systemic effect -a histopathological and immunohistochemical study. BMC Cancer 2001;1:7.
25. Pflanz S, Brookman-Amissah S, Roigas J, Kendel F, Hoschke B, May M. Impact of macroscopic tumour necrosis to predict survival of patients with surgically resected renal cell carcinoma. Scand J Urol Nephrol 2008;42:507-13. doi: 10.1080/00365590802460633
26. Zhang L, Conejo-Garcia JR, Katsaros D, Gimotty PA, Massobrio M, Regnani G, et al. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med 2003;348:203-13. doi: 10.1056/NEJMoa020177
27. Murakami R, Sugahara T, Nakamura H, Hirai T, Kitajima M, Hayashida Y, et al. Malignant supratentorial astrocytoma treated with postoperative radiation therapy: prognostic value of pretreatment quantitative diffusionweighted MR imaging. Radiology 2007;243: 493-9.
28. Yamasaki F, Sugiyama K, Ohtaki M, Takeshima Y, Abe N, Akiyama Y, et al. Glioblastoma treated with postoperative radio-chemotherapy: prognostic value of apparent diffusion coefficient at MR imaging. Eur J Radiol 2010;73:532-7. doi: 10.1016/j. ejrad.2009.01.013
29. Barajas RF Jr., Rubenstein JL, Chang JS, Hwang J, Cha S. Diffusion-weighted MR imaging derived apparent diffusion coefficient is predictive of clinical outcome in primary central nervous system lymphoma. AJNR Am J Neuroradiol 2010;31:60-6. doi: 10.3174/ajnr.A1750
30. Padera TP, Kuo AH, Hoshida T, Liao S, Lobo J, Kozak KR, et al. Differential response of primary tumor versus lymphatic metastasis to VEGFR-2 and VEGFR-3 kinase inhibitors cediranib and vandetanib. Mol Cancer Ther 2008;7:2272-9. doi: 10.1158/1535-7163. MCT-08-0182
31. Tam HH, Colins DJ, Brown G, Chau I, Cunningham D, Leach MO, et al. High pre-treatment apparent diffusion coefficient predicts poor disease survival in patients with colorectal hepatic metastasis. In: Joint Annual Meeting ISMRM-ESMRMB; 1-7 May 2010; Stockholm, Sweden.